Abstract
Good glycaemic control continues to be the most effective therapeutic manoeuvre to reduce the risk of development and/or progression of microvascular disease, and therefore remains the cornerstone of diabetes management despite recent scepticism about tight glucose control strategies. The impact on macrovascular complications is still a matter of debate, and so glycaemic control strategies should be placed in the context of multifactorial intervention to address all cardiovascular risk factors. Approaches to achieve glycaemic targets should always ensure patient safety, and results from recent landmark outcome studies support the need for appropriate individualisation of glycaemic targets and of the means to achieve these targets, with the ultimate aim to optimise outcomes and minimise adverse events, such as hypoglycaemia and marked weight gain. The primary goal of the Global Partnership for Effective Diabetes Management is the provision of practical guidance to improve patient outcomes and, in this article, we aim to support healthcare professionals in appropriately tailoring type 2 diabetes treatment to the individual. Patient groups requiring special consideration are identified, including newly diagnosed individuals with type 2 diabetes but no complications, individuals with a history of inadequate glycaemic control, those with a history of cardiovascular disease, children and individuals at risk of hypoglycaemia. Practical guidance specific to each group is provided.
Original language | English |
---|---|
Pages (from-to) | 295-304 |
Number of pages | 10 |
Journal | International Journal of Clinical Practice |
Volume | 64 |
Issue number | 3 |
Early online date | 11 Jan 2010 |
DOIs | |
Publication status | Published - Feb 2010 |
Bibliographical note
© 2010 Blackwell Publishing LtdRe-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
Keywords
- adult
- blood glucose
- child
- type 2 diabetes mellitus
- diabetic angiopathies
- humans
- hypoglycemia
- hypoglycemic agents
- obesity
- overweight
- practice guidelines as topic
- thinness